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ABSTRACT 
Introduction: Hypothermia improves survival and neurological recovery after cardiac arrest. 
Pro-inflammatory cytokines have been implicated in focal cerebral ischemia/reperfusion in-
jury. It is unknown whether cardiac arrest also triggers the release of cerebral inflammatory 
molecules,  and  whether  therapeutic  hypothermia  alters  this  inflammatory  response.  This 
study sought to examine whether hypothermia or the combination of hypothermia with anes-
thetic postconditioning with sevoflurane affect cerebral inflammatory response after cardio-
pulmonary resuscitation. 
Methods: Thirty pigs (28 - 34kg) were subjected to cardiac arrest following temporary coro-
nary artery occlusion. After 7 minutes of ventricular fibrillation and 2 minutes of basic life 
support, advanced cardiac life support was started according to the current AHA guidelines. 
Return of spontaneous circulation was achieved in 21 animals who were randomized to ei-
ther normothermia at 38° C, hypothermia at 33° C or hypothermia at 33° C combined with se-
voflurane (each group: n = 7) for 24 hours. The effects of hypothermia and the combination 
of hypothermia with sevoflurane on cerebral inflammatory response after cardiopulmonary 
resuscitation were studied using tissue samples from the cerebral cortex of pigs euthanized 
after 24 hours and employing quantitative RT-PCR and ELISA techniques.  
Results: Global cerebral ischemia following resuscitation resulted in significant upregulation 
of cerebral tissue inflammatory cytokine mRNA expression (mean ± SD; interleukin (IL)-1β 
8.7 ± 4.0, IL-6 4.3 ± 2.6, IL-10 2.5 ± 1.6, tumor necrosis factor (TNF)α 2.8 ± 1.8, intercellular 
adhesion molecule-1 (ICAM-1) 4.0 ± 1.9-fold compared with sham control) and IL-1β protein 
concentration (1.9 ± 0.6-fold compared with sham control). Hypothermia was associated with 
a  significant  (P  <0.05  versus  normothermia)  reduction  in  cerebral  inflammatory  cytokine 
mRNA expression (IL-1β 1.7 ± 1.0, IL-6 2.2 ± 1.1, IL-10 0.8 ± 0.4, TNFα 1.1 ± 0.6, ICAM-1 
1.9 ± 0.7-fold compared with sham control). These results were also confirmed for IL-1β on 
protein level. Experimental settings employing hypothermia in combination with sevoflurane 
showed that the volatile anesthetic did not confer additional anti-inflammatory effects com-
pared with hypothermia alone. Conclusions:  Mild  therapeutic  hypothermia  resulted  in  decreased  expression  of  typical 
cerebral  inflammatory  mediators  after  cardiopulmonary  resuscitation.  This  may  confer,  at 
least in part, neuroprotection following global cerebral ischemia and resuscitation.  
    
INTRODUCTION 
Although initial return of spontaneous circulation (ROSC) from cardiac arrest is achieved in 
about 30-40% of cases, only 10-30% of the patients admitted to the hospital will be dis-
charged with good outcome [1]. One third of those who survive, suffer persistent neurological 
impairments [2]. Mild therapeutic hypothermia has emerged as the most effective strategy to 
reduce  neurological  impairment  after  successful  cardiopulmonary  resuscitation  (CPR)  [3]. 
The precise mechanisms by which mild hypothermia protects brain cells remain to be eluci-
dated, but it is very likely that hypothermia acts upon multiple pathways including reduction in 
cerebral metabolism and oxygen consumption, attenuation of neuronal damage, and inhibi-
tion of excitatory neurotransmitter release [4].  
There is growing evidence on the damaging nature of the inflammatory response following 
brain ischemia. Various inflammatory cytokines have been implicated as important mediators 
of ischemia/ reperfusion injury following both focal and global cerebral ischemia [5]. Most of 
the previous experimental studies induced global cerebral ischemia by bilateral carotid artery 
occlusion as a correlate of cardiac arrest, but inflammatory response mechanisms following 
carotid artery occlusion and anti-inflammatory mechanisms of hypothermia may be different 
from that observed after cardiac arrest and manual CPR. Thus, it is unknown whether car-
diac arrest also triggers the release of cerebral inflammatory molecules, and whether thera-
peutic hypothermia alters this inflammatory response.  
Neuronal injury may also result in necrotic and apoptotic cell death. In contrast to necrosis 
(cell death by acute injury), apoptosis is a well-regulated physiological process. Cells under-
going apoptosis are characterized by cytoplasmic shrinkage, nuclear condensation, and for-
mation  of  membrane-bound  vesicles.  Key  elements  of  the  apoptotic  pathway  include 
changes  in  the  gene  expression  of  the  pro-apoptotic  protein  Bax  and  the  apoptosis-
suppressing  protein  Bcl-2.  The  extent  to  which  hypothermia  affects  cerebral  apoptosis-
related proteins after successful CPR is not clear [4].  
The mismatch between early survival and final outcome after CPR emphasizes the impor-
tance of further research on potential adjuvants in addition to mild hypothermia. Specifically,  
pharmacological  postconditioning  may  offer  an  attractive  opportunity  to further  ameliorate 
damage to the brain in the post-resuscitation period. While the volatile anesthetic sevoflurane 
has emerged as a preconditioning-like agent with significant neuroprotective effects in mod-
els  of  focal  and  global  cerebral  ischemia  [6],  its  potential  neuroprotective  and  anti-
inflammatory properties have not yet been investigated in the context of postresuscitation 
care. Thus, a combination of hypothermia and anesthetic postconditioning with sevoflurane 
may extend neuroprotection, as it has recently been shown for the noble anesthetic gas xe-
non combined with hypothermia after neonatal hypoxia-ischemia [7]. 
We hypothesized that hypothermia attenuates cerebral inflammatory response in a pig model 
of global cerebral ischemia following cardiac arrest. We further hypothesized that the volatile 
anesthetic sevoflurane - when administered during reperfusion after successful CPR –confer 
additional anti-inflammatory effects.   
MATERIALS AND METHODS 
The  project  was  approved  by  the  Animal  Investigation  Committee  of  the  University 
Schleswig-Holstein, Campus Kiel, Germany, and animals were managed in accordance with 
the guidelines of the University Schleswig-Holstein, Campus Kiel, Germany, and the Utstein-
style guidelines [8]. All animals received human care in compliance with the ”Guide for the 
Care and Use of Laboratory Animals” published by the National Institute of Health (NIH Pub-
lication No. 88.23, revised 1996). 
Animals 
This is an experimental study on 40 healthy pigs (cardiac arrest: n=30; sham control: n=5; 
excluded from study n=5) aged 3-4 months of both gender, weighing 28 to 34 kg. Anesthesia 
was initiated by intramuscular injection of 8 mg/kg azaperone and 0.05 mg/kg atropine, and 
completed by intravenous injection of 1-2 mg/kg propofol and 0.3 µg/kg sufentanil. After en-
dotracheal intubation, pigs were ventilated with a volume-controlled ventilator (Draeger, Sulla 
808V, Luebeck, Germany) and the following setting: a FiO2 of 0.3 at 20 breaths/minute, a 
tidal volume of 8 mL/kg to maintain normocapnia, and a positive end-expiratory pressure of 5 
mm Hg. Ventilation was monitored using an inspired/expired gas analyzer that measured 
oxygen and end-tidal carbon dioxide (suction rate, 200 mL/min; M-PRESTN; Datex-Ohmeda 
Inc., Helsinki, Finland). Total intravenous anesthesia (TIVA) was maintained by continuous 
infusion of 4-8 mg/kg/h propofol and 0.3 µg/kg/h sufentanil; muscle relaxation was achieved 
by continuous infusion of 0.2 mg/kg/h pancuronium. Depth of anesthesia was judged accord-
ing to blood pressure, heart rate and Bispectral Index (BISXP, Aspect Medical Systems, Na-
tick, MA) [9]. In order to assure an appropriate depth of anesthesia we performed also indi-
rect measures such as tail clamping, monitoring of the corneal reflex and lacrimation, as well 
as changes in hemodynamics and heart rate. If assessment suggested inadequate level of 
anesthesia, additional sufentanil and propofol was injected. Ringer’s solution was adminis-
tered continuously throughout the preparation phase to replace fluid loss during instrumenta-
tion. Standard leads II and V5 electrocardiogram were used to monitor cardiac rhythm.  
A 7F saline filled central venous catheter was inserted in the right internal jugular vein for 
drug administration. A 4F thermistor-tipped catheter for arterial thermodilution (Pulsion Medi-
cal Systems, Munich, Germany) was inserted percutaneously into the right femoral artery. 
The arterial catheter was connected to the PiCCO system (PiCCO plus, Software Version 
6.0, Pulsion Systems, Munich, Germany), and the resulting signal processed to determine 
mean  arterial  blood  pressure,  heart  rate,  and  blood  temperature.  In  addition,  the  arterial 
catheter allowed discontinuous measurement of transpulmonary cardiac output by injecting 
10 mL ice cold saline into the proximal port of the central venous catheter. The mean of three 
consecutive measurements randomly assigned to the respiratory cycle was used for deter-
mination of cardiac output. Cardiac index was calculated as the ratio of cardiac output/ body 
surface area (body surface area = 0.0734*(body weight in kg)
0.656 [10]). Intravascular cathe-
ters  were  attached  to  pressure  transducers  (Smiths  Medical,  Kirchseeon,  Germany)  that 
were aligned at the level of the right atrium.  
Experimental protocol  
The experimental time line is presented in figure 1. Because the majority of patients experi-
ence cardiac arrest due to myocardial ischemia [11], and because this scenario has only 
been considered in few animal experiments, our study is based on an experimental porcine 
model of cardiac arrest following acute coronary artery ischemia reflecting a realistic clinical 
setting. Five healthy animals served as sham controls, which were anesthetized with TIVA 
until the end of the experiment. Thirty-five pigs underwent left anterior descending (LAD) 
coronary artery occlusion for 60 minutes according to the technique previously described 
[12].  Five  pigs  fibrillated  spontaneously  following  left  anterior  descending  coronary  artery 
occlusion, which were excluded from further analysis. Thirty pigs were then subjected to car-
diac  arrest  twenty  minutes  after  LAD  occlusion.  Ventricular  fibrillation  was  electrically-
induced by an alternating current of 5 to 10 V in a standardized manner, and mechanical 
ventilation was discontinued. After a 7-minutes non-intervention interval of untreated ven-
tricular  fibrillation,  basic  life  support  CPR  was  simulated  for  2  minutes  applying  external 
manual  closed  chest  compressions  at  a  rate  of  100  per  minute,  and  a  compression-to- 
ventilation ratio of 30:2. Subsequently, advanced cardiac life support was started with 100 J 
biphasic defibrillation attempt (M-Series Defibrillators, Zoll Medical Corporation, Chelmsford, 
USA), all subsequent attempts were performed with 150 J every 2 minutes. Ventilations were 
performed with 100 % oxygen at 20 breaths/ minute. All pigs received 45 µg/kg epinephrine 
and 0.4 U/kg vasopressin alternating as suggested by the AHA guidelines [13]. ROSC was 
defined as maintenance of an unassisted pulse and a systolic aortic blood pressure of ≥ 60 
mm  Hg  lasting  for  ten  consecutive  minutes  according  to  the  Utstein-style  guidelines  [8]. 
Since neurological recovery is very unlikely after 30 minutes of normothermic cardiac arrest, 
CPR was terminated, when resuscitation remained unsuccessful after 23 minutes of CPR. 
After ROSC, animals were randomized either to normothermia (38° C) plus TIVA (NT), hypo-
thermia (33° C) plus TIVA (HT), or hypothermia (33° C) combined with 2.0 Vol% end-tidal se-
voflurane and 0.3 µg/kg/h sufentanil (HT+SEV). Since hypothermia was shown to increase 
blood concentrations of propofol by about 30% [14], we reduced continuous infusion of pro-
pofol during hypothermia targeting bispectral index values below 60. Body core temperature 
was monitored continuously by the arterial catheter, and normothermic body temperature 
was maintained at 38.0° C with a heating blanket, since the physiological rectal temperature 
of pigs is supposed to be about 38° C [15]. Hypothermia was induced by 1000 mL saline 
(4° C) and maintained by a cooling device (Icy catheter and CoolGard 3000; Alsius Corp, Ir-
vine, USA) that was introduced into the femoral vein. According to the landmark study by 
Bernard et al. [16] we used a target body temperature of 33° C for 12 hours. Thereafter, re-
warming was initiated (0.5° C per hour). One hour after ROSC, FiO2 was reduced to 0.4. Dur-
ing the post-resuscitation period, animals received crystalloid infusions to keep central ve-
nous pressure above 8 mm Hg and mean arterial blood pressure above 50 mm Hg. If this 
first  step  failed,  additional  norepinephrine  was  administered  to  keep  mean  arterial  blood 
pressure above 50 mm Hg. We further aimed at serum glucose levels less than 150 mg/dL 
by intermittent insulin bolus administration. Animals were killed by an overdose of sufentanil, 
propofol and potassium chloride 24 hours after ROSC. Tissue samples of the cerebral cortex 
were collected within 15 seconds following euthanasia via a craniotomy that was established  
before euthanasia, and then immediately snap-frozen in liquid nitrogen (stored at -80° C) to 
minimize time-dependent effects of cerebral ischemia following euthanasia on cytokine ex-
pression. Autopsy was routinely performed for documentation of potential injuries to the tho-
racic and abdominal cavity during CPR.  
Hemodynamic data, including mean arterial blood pressure, heart rate, end-tidal carbon diox-
ide, and cardiac index were determined at baseline (BL), following ROSC, and 7 and 24 
hours after ROSC, respectively. 
Quantitative real-time RT-PCR  
Transcript levels of interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor (TNF)α, intercellular 
adhesion  molecule  (ICAM)-1,  and  the  apoptosis-associated  proteins  Bcl-2  and  Bax  were 
investigated in the cerebral cortex tissue of all surviving animals and compared with tissue of 
sham control animals. Tissue samples were analyzed by a person blinded to treatment as-
signment. Fully detailed description of quantitative real-time RT-PCR is presented in the Ad-
ditional File 1 and Table S1 [17-20]. 
Enzyme-linked immunosorbent assay (ELISA) 
Protein concentrations of IL-1β were determined by a swine specific ELISA (BioSource Inter-
national, Inc. Camarillo, USA) in homogenates of frozen tissues according to the manufac-
turer’s protocol. All ELISA assays were carried out in duplicates. 
Statistical analysis 
Statistics were performed using commercially available statistics software (GraphPad Prism 
version 5.02 for Windows, GraphPad Software, San Diego, CA). Survival rates were com-
pared using Fisher’s exact test. Statistical analysis was performed with a one-way analysis of 
variance (ANOVA) followed by a Bonferroni post hoc test to correct for multiple measure-
ments. RT-PCR data analysis was performed according to a relative standard curve method 
using an Excel spreadsheet, and statistical significance was tested using two-sided Pair-wise 
fixed Reallocation Randomisation Test, as provided in the REST2005 program [20]. Mann-
Whitney test was used for analysis of protein concentrations of IL-1β were normal distribution  
was not expected. Variables are expressed as mean±SD unless otherwise specified. Statisti-
cal significance was considered at a two-sided p value of ≤ 0.05.    
RESULTS 
Cardio-pulmonary resuscitation  
Twenty-one  animals  were  successfully  resuscitated.  Detailed  resuscitation  data  are  pre-
sented in table 1. In the NT group, 5 out of 7 animals survived for 24 hours compared to all 
animals in the HT and HT+SEV group (p=0.46 vs. NT). Two animals of the NT group died 
due to hemodynamic instability during the post-resuscitation period. 
Postresuscitation hemodynamics  
Postresuscitation  systemic  hemodynamic  variables  are  presented  in  table  2.  Heart  rate, 
mean arterial blood pressure and cardiac index did not significantly differ between groups. 
Cumulative crystalloid fluid load and cumulative norepinephrine doses were not significantly 
different  between  groups  24  hours  after  ROSC  [volume  load  (p=0.540),  norepinephrine 
doses (p=0.812); NT: 4241±1244 mL, 4.4±1.6 mg; HT: 3987±932 mL, 4.9±2.1 mg; HT+SEV: 
4627±1056 mL, 5.1±1.8 mg]. 
Cerebral inflammatory response 
Global cerebral ischemia following resuscitation resulted in a significant upregulation of cere-
bral tissue inflammatory cytokine mRNA expression (NT: IL-1β 8.7±4.0, IL-6 4.3±2.6, IL-10 
2.5±1.6, TNFα 2.8±1.8, ICAM-1 4.0±1.9-fold compared with sham control) and IL-1β protein 
concentration (1.9±0.6-fold compared with sham control). Hypothermia was associated with 
significantly  (p<0.05  versus  normothermia)  less  upregulation  of  mRNA  expression  (IL-1β 
1.7±1.0,  IL-6  2.2±1.1,  IL-10  0.8±0.4,  TNFα  1.1±0.6,  ICAM-1  1.9±0.7-fold  compared  with 
sham control) and IL-1β protein concentration (1.3±0.4-fold compared with sham control). 
Sevoflurane did not confer statistically significant (versus hypothermia) additional protective 
effects neither on mRNA (IL-1β 1.2±0.6, IL-6 2.0±0.9, IL-10 0.7±0.3, TNFα 0.9±0.4, ICAM-1 
1.8±0.6-fold compared with sham control) nor on protein levels (1.1±0.2-fold compared with 
sham control; Fig. 2, 3). 
Bax and Bcl-2 mRNA expression 
We found a significant (p<0.01) upregulation of both Bcl-2 mRNA and Bax expression after 
global cerebral ischemia (NT: Bcl-2 3.2±1.8-fold, Bax 2.3±1.3-fold compared with sham con- 
trol). Hypothermia was associated with significantly (p<0.05) less upregulation of mRNA ex-
pression (Bcl-2 1.2±0.5-fold, Bax 1.2±0.6-fold compared with sham control). Sevoflurane did 
not confer additional effects (Bcl-2 1.1±0.4-fold, Bax 1.1±0.4-fold compared with sham con-
trol; Fig. 4). 
  
DISCUSSION 
Neurological dysfunction resulting from cardiac arrest largely contributes to morbidity and 
mortality after initially successful CPR [21]. Employing a pig model we showed that (i) global 
cerebral  ischemia  following  cardiac  arrest  and  CPR  results  in  upregulation  of  pro-
inflammatory cytokine expression in the cerebral tissue, ii) mild hypothermia significantly re-
duces cerebral tissue inflammatory response, and (iii) pharmacological postconditioning with 
sevoflurane does not confer additional anti-inflammatory effects on cerebral tissue. 
Cerebral inflammatory response following resuscitation 
Mechanisms of brain injury following cerebral ischemia are complex with multiple modulators, 
signaling pathways, proteins and enzymes being involved that may facilitate cell death or 
survival [22]. Post-ischemic inflammation has been shown to play a critical role in cerebral 
ischemia/reperfusion injury [23]. Specifically, there is strong evidence suggesting that a dis-
proportionate and persistent production of cytokines can significantly increase the risk and 
extent of brain injury [5, 24]. In terms of a systemic inflammatory response, increased serum 
levels of different cytokines and chemokines have recently been presented in a rat model of 
cardiac arrest [25], and in patients successfully resuscitated from out-of-hospital cardiac ar-
rest [26, 27]. The role of the cerebral inflammatory response after cardiac arrest, however, 
has  poorly  been  investigated.  Most  of  the  previous  experimental  studies  induced  global 
cerebral ischemia by bilateral carotid artery occlusion as a surrogate of cardiac arrest, but 
inflammatory response mechanisms following carotid artery occlusion and anti-inflammatory 
mechanisms of hypothermia are different from the ones observed after cardiac arrest and 
resuscitation [27]. Youngquist et al. [28] have recently shown increased TNFα and IL-6 pro-
tein concentration in the cerebrospinal fluid following cardiac arrest. Since the presence of a 
lesion pattern of cortical involvement, termed as ‘extensive cortical lesion pattern’ in MR im-
aging, has very recently been shown to be a very good predictor of poor neurologic progno-
sis after cardiac arrest [29], we focused on neuroinflammation in the cerebral cortex tissue. In 
our study, global cerebral ischemia following cardiac arrest resulted in a significant upregula-
tion of mRNA expression of several cytokines in the cerebral cortex tissue. In addition, we  
observed a significant rise in IL-1β protein concentration in the cerebral cortex tissue that 
may be most probably due to local synthesis primarily by microglial cells, astrocytes and/or 
endothelial cells [30] rather than transport across the blood–brain barrier. This is emphasized 
by the data of Mizushima and colleagues who demonstrated that the integrity of the blood–
spinal cord and blood–brain barriers to radiolabelled TNFα remains intact following resuscita-
tion in a mouse model of cardiac arrest [31].  
Effects of hypothermia on cerebral inflammatory response 
Several mechanism by which hypothermia exerts its protective effects have been character-
ized, including reduction in excitotoxin accumulation and inhibition of molecular pathways 
such as apoptosis and necrosis [4]. The role of inflammation in global cerebral ischemia in-
duced by bilateral carotid artery occlusion and focal cerebral ischemia has extensively been 
studied, but effects of hypothermia on global cerebral ischemia/reperfusion injury following 
cardiac arrest has been investigated to a much lesser extent. Webster et al. have previously 
found  that  mild  hypothermia  attenuated  microglial  activation  and  nuclear  translocation  of 
NFκB, and thereby reduced activation of the downstream inflammatory pathway [32]. Con-
sidering the relatively late onset of the inflammatory response and the prolonged destructive 
process following cerebral ischemia/reperfusion, there appears to be a reasonable therapeu-
tic time window using mild hypothermia to favourably affect the inflammatory pathway [33]. 
To date, the majority of publications may suggest that hypothermia simply blocks any ische-
mia-induced damaging cascade. However, contrary to this popular belief, the expression of 
certain  beneficial  genes  is  actually  upregulated  by  mild  hypothermia  [4].  Hicks  and  col-
leagues [34] further demonstrated that prolonged hypothermia during later reperfusion im-
proved neurological outcome after experimental global ischemia and was associated with 
selective changes in the pattern of stress-induced protein expression. From our data we con-
clude that mild hypothermia initiated after successful resuscitation from cardiac arrest re-
duces pro-inflammatory cytokine, IL-10, and ICAM-1 mRNA expression compared to nor-
mothermia.  Inhibition  of  adhesion  molecule  expression  and  microglial  activation  has  also 
been confirmed by Deng and colleagues in rat models of both focal cerebral ischemia and  
brain inflammation [35]. Thus, the beneficial effects of hypothermia on neuroprotection are 
considered to be due, in part, to suppression of post-injury pro-inflammatory factors by mi-
croglia. However, the role of hypothermia in modulating anti-inflammatory cytokines, e.g. IL-
10, remains controversial. While mild hypothermia has been shown to increase plasma IL-10 
concentration in endotoxemic rats, thus potentially mediating the anti-inflammatory effects of 
hypothermia  [36,  37],  Matsui  et  al.  [38]  and  Russwurm  et  al.  [39]  have  previously 
demonstrated  that  mild  hypothermia  inhibits  IL-10  production  in  peripheral  blood 
mononuclear cells. Interestingly, in lipopolysaccharide-activated cultured microglia cells iso-
lated from rats, hypothermia has also been found to reduce production of IL-6, IL-10, and 
nitric oxide, suggesting that the neuroprotective effects of hypothermia might involve not only 
the inhibition of pro-inflammatory factors, but also the inhibition of anti-inflammatory factor(s) 
[40]. Comparably, we found less upregulation of IL-10 mRNA expression in the cerebral tis-
sue in the hypothermia group compared to normothermia after successful CPR. 
Since IL-1β was one of the cytokines that was strongly up-regulated on mRNA level in our 
study, we decided to evaluate IL-1β expression also on the protein level. Analysis of cerebral 
cortex tissue using a swine specific ELISA system revealed significantly increased IL-1β pro-
tein  concentration  compared  with  the  sham  control  group  after  cardiac  arrest  and  nor-
mothermia  but  not  after  hypothermia. Interestingly,  Callaway  et  al.  have  recently  demon-
strated that hypothermia after cardiac arrest did not alter serum inflammatory markers, sug-
gesting that circulating cytokines may not play a specific role regarding the neuroprotective 
effect of hypothermia [25]. In contrast, it is well conceivable, that local cerebral cytokines 
released by brain cells will affect more extensively various cerebral ischemia/reperfusion in-
jury cascades and will have a much broader effect on brain damage than systemically ele-
vated levels of cytokines.  
Concerning reliable biochemical markers of brain tissue damage, increased serum levels of 
the low molecular weight protein S100B have been reported after cardiac arrest correlating 
with neurological complications. However, mild therapeutic hypothermia did not affect S100B 
serum levels in survivors of cardiac arrest in several clinical studies [41, 42]. In addition, Xiao  
and colleagues have previously shown that cardiac arrest significantly increased brain mye-
loperoxidase  activity,  but  again,  mild  hypothermia  had  no  effect.  Thus,  the  hypothermia-
elicited neuroprotection seemed not to be neutrophil-dependent, at least in that rat model of 
asphyxial cardiac arrest [43]. 
Effects of pharmacological postconditioning on cerebral inflammatory response 
Volatile anesthetic agents have emerged as preconditioning-like agents with significant neu-
roprotective effects and the ability to reduce excitotoxic induced cell death, to decrease cere-
bral metabolic rate, to activate inducible nitrous oxide synthase and p38 mitogen-activated 
protein kinases, and to improve neurological deficits in models of both focal and global cere-
bral ischemia [6, 44, 45]. Most experimental studies have documented improved functional 
performance when neuroprotective agents were given before the insult. In patients with car-
diac arrest, however, pretreatment is virtually impossible because of the unpredictable onset 
of ischemia. Therefore, as in our study, potential protective interventions should be initiated 
during or after experimental ischemia to affect reperfusion injury. In this context, pharmacol-
ogical postconditioning with volatile anesthetics in addition to mild hypothermia may offer an 
attractive  opportunity  to  further  ameliorate  brain  damage  and  inflammation  in  the  post-
resuscitation period. The effects of volatile agents on the inflammatory response after cardiac 
arrest have not yet been elucidated. In endotoxemic rats, inhalation of sevoflurane signifi-
cantly attenuated plasma levels of TNFα and IL-1β [46]. In addition, sevoflurane postcondi-
tioning showed anti-inflammatory and anti-necrotic effects in cultured kidney proximal tubule 
cells [47], and sevoflurane attenuated the inflammatory response upon stimulation of alveolar 
macrophages with endotoxin in vitro [48]. In our study, however, sevoflurane administered 
instead of propofol during reperfusion after successful CPR did not further attenuate local 
cerebral inflammatory response. These observations are comparable to those obtained in a 
study by Fries et al. where the volatile anesthetic isoflurane did not reduce neurological dys-
function and histopathological alterations induced by cardiac arrest [49]. However, it is con-
ceivable that hypothermia alone has such potent anti-inflammatory properties compared to 
normothermia, that an additional effect of sevoflurane could not be revealed in the present  
study.  Moreover,  potential  protective  effects  of  volatile  anesthetics  depend  on  energy-
dependent signal transduction, e.g. protein synthesis and phosphorylation [50], that may be 
affected by hypothermia-induced decrease of metabolic rate as well as suppression of pro-
tein synthesis. 
Cerebral apoptosis-related mRNA expression  
In  the  cerebral  cortex  tissue,  we  found  a  significant  upregulation  of  both  Bcl-2  and  Bax 
mRNA expression after global cerebral ischemia. Comparably, Mishra and colleagues have 
recently reported increased apoptosis in a pig model of cerebral hypoxia for 60 minutes, indi-
cated by an increased ratio of Bax/ Bcl-2 protein concentration, activation of caspase-9, lipid 
peroxidation, and DNA fragmentation in mitochondria of the cerebral cortex [51].  
Besides the regulation of inflammatory molecules, mild therapeutic hypothermia significantly 
attenuated the mRNA expression of the apoptosis-regulating proteins Bax and Bcl-2 in our 
study. These results are partly comparable to the findings of Eberspächer et al. [52, 53], 
where  hypothermia  prevented  an  ischemia-induced  increase  of  the  pro-apoptotic  protein 
Bax, but did not change or even increased expression of the anti-apoptotic protein Bcl-2. 
Potential discrepancies between the work presented here and those in the literature could be 
due to the type of species and duration of ischemia. In our pig model 7 minutes of cardiac 
arrest  were  followed  by  resuscitation  compared  with  the  latter  studies  investigating  a  rat 
model of common carotid artery occlusion plus hemorrhagic hypotension [52, 53]. In a similar 
rat model of cerebral ischemia, Pape et al investigated the effects of sevoflurane on neuronal 
damage and expression of apoptic factors. Sevoflurane was administered before, during and 
after cerebral ischemia, and has been found to modulate the balance between pro- and anti-
apoptotic key proteins towards a reduction of active programmed cell death by increasing the 
hippocampal concentration of the anti-apoptotic proteins Bcl-2, and by inhibiting the ische-
mia-induced upregulation of the pro-apoptotic protein Bax [54].  
In our pig model of cardiac arrest, however, sevoflurane postconditioning combined with mild 
hypothermia did not confer additional effects in terms of apoptotic-related mRNA expression.  
Again, it is conceivable that hypothermia alone has such potent anti-apoptotic effects, that an 
additional effect of sevoflurane could not be revealed in the present study. 
Limitations 
Although we used a porcine model of cardiac arrest following myocardial ischemia reflecting 
a common clinical scenario, there are several points that need to be addressed in future 
studies: (i) both long-term survival and neurological outcome were not evaluated because of 
limitations posed by governmental regulations; therefore, we did not assess the relationship 
between the upregulation of cytokines and post-resuscitation cerebral dysfunction. (ii) Blind-
ing the investigator was not possible throughout the experiment due to cooling technique, but 
tissue samples were analyzed by a person blinded to treatment assignment.  
 
CONCLUSIONS 
In conclusion, (i) global cerebral ischemia following cardiac arrest results in up-regulation of 
pro-inflammatory  cytokines.  (ii)  Hypothermia  after  cardiac  arrest  reduces  up-regulation  of 
various cytokines in the cerebral tissue. This may promote, at least in part, neuroprotection. 
(iii) The volatile anesthetic sevoflurane - when administered during reperfusion after success-
ful CPR – did not confer statistically significant additional anti-inflammatory effects in the 
above setting.  
 
 
 
 
 
 
 
 
 
  
KEY MESSAGES 
-  Global cerebral ischemia following cardiac arrest results in up-regulation of local pro-
inflammatory cytokines expression. 
-  Mild hypothermia after cardiac arrest attenuates cerebral inflammatory response. 
-  Sevoflurane does not confer additional anti-inflammatory effects. 
-  Further studies on the relationship between cerebral inflammatory response and post-
resuscitation cerebral dysfunction are warranted. 
 
ABBREVIATIONS 
CPR: cardiopulmonary resuscitation; ELISA: enzyme-linked immunosorbent assay; HT: hy-
pothermia; ICAM-1: intercellular adhesion molecule –1; IL: interleukin; LAD: left anterior de-
scending (coronary artery); NT: normothermia; ROSC: return of spontaneous circulation; RT-
PCR: reverse transcriptase polymerase chain reaction; SEV: sevoflurane; TIVA:  total  intra-
venous anesthesia; TNFα: tumor necrosis factor α; VF: ventricular fibrillation. 
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FIGURE LEGENDS 
Figure 1. Experimental time line. Thirty pigs were subjected to cardiac arrest following left 
anterior descending (LAD) coronary artery ischemia. Ventricular fibrillation (VF) was electri-
cally induced twenty minutes after LAD occlusion. After 7 minutes of VF, pigs were resusci-
tated (CPR). After successful return of spontaneous circulation (ROSC; n=21), coronary per-
fusion was reestablished after 60 minutes of LAD occlusion, and animals were randomized 
either to normothermia at 38° C, hypothermia at 33° C or hypothermia at 33° C combined with 
sevoflurane (each group n=7) for 24 hours. Five animals were sham operated. In the nor-
mothermia group, 5 out of 7 animals survived for 24 hours compared to all animals in the 
hypothermia and hypothermia combined with sevoflurane group. 
Figure 2. Cerebral cytokine mRNA expression. Transcript levels of the cerebral cytokines 
interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor (TNF)α and intercellular adhesion mole-
cule (ICAM)-1 were determined by quantitative RT-PCR. NT, normothermia; HT, hypother-
mia; HT+SEV, hypothermia combined with sevoflurane. Data are expressed as mean±SD (x-
fold  upregulation  compared  with  Sham  control).  *p<0.05,  †p<0.01  vs.  Sham.  §p<0.05, 
#p<0.01 vs. NT. RT-PCR data analysis was performed using two-sided Pair-wise fixed Real-
location Randomisation Test. 
Figure 3. Protein concentration of interleukin-1β. Protein concentration of interleukin (IL)-
1β  was  determined  by  a  swine  specific  enzyme-linked-immunosorbent  assay.  NT,  nor-
mothermia; HT, hypothermia; HT+SEV, hypothermia combined with sevoflurane. Data are 
expressed  as  mean±SD  (x-fold  upregulation  compared  with  Sham  control).  *p<0.05  vs. 
Sham. §p<0.05, #p<0.01 vs. NT (using Mann-Whitney test). 
Figure  4.  Cerebral  Bcl-2  and  Bax  mRNA  expression. Transcript  levels  of the  cerebral 
apoptosis-associated proteins Bcl-2 and Bax were determined by quantitative RT-PCR. NT, 
normothermia; HT, hypothermia; HT+SEV, hypothermia combined with sevoflurane. Data are 
expressed  as  mean±SD  (x-fold  upregulation  compared  with  Sham  control).  *p<0.05  vs. 
Sham.  §p<0.05  vs.  NT.  RT-PCR  data  analysis  was  performed  using  two-sided  Pair-wise 
fixed Reallocation Randomisation Test.  
    
Table 1. Cardiopulmonary resuscitation data. 
  NT  HT  HT+SEV  p values 
ROSC rate [n]  7/ 10  7/ 10  7/ 10  - 
CPR time to successful 
resuscitation [min] 
9.7 ± 2.8  10.3 ± 3.4  10.5 ± 3.1  0.939 
Cumulative epinephrine 
dose [µg/kg] 
100 ± 44  101 ± 47  93 ± 33  0.828 
Cumulative vasopressin 
dose [IU/kg] 
0.8 ± 0.2  0.8 ± 0.3  0.8 ± 0.3  0.897 
Cumulative defibrillation 
energy [J] 
755 ± 420  703 ± 413  795 ± 199  0.854 
CorPP 10 [mm Hg]  31 ± 9  26 ± 11  28 ± 6  0.559 
CorPP 15 [mm Hg]  39 ± 28  40 ± 25  38 ± 24  0.890 
Time to target tempera-
ture 33° C [min] 
-  47 ± 10  45 ± 15  - 
Return  of  spontaneous  circulation  (ROSC),  cardiopulmonary  resuscitation  (CPR)  time  to 
successful resuscitation, cumulative epinephrine and vasopressin dose, cumulative defibrilla-
tion energy, coronary perfusion pressure (CorPP) 10 and 15 minutes after induction of ven-
tricular fibrillation, and induction time to target temperature of 33° C. NT indicates normother-
mia; HT, hypothermia; HT+SEV, hypothermia combined with sevoflurane. Data are mean ± 
SD.  
Table 2. Hemodynamic data. 
  NT  HT  HT+SEV  P value 
Baseline         
HR, beats/minute  107±21  105±14  96±15  0.342 
MAP, mm Hg  65±13  70±11  71±13  0.314 
ETco2, mm Hg  40±5  36±4  37±5  0.180 
CI, L/min/m
2  7.4±1.8  6.8±1.3  7.4±1.7  0.580 
ROSC         
HR, beats/minute  94±18  99±33  96±21  0.988 
MAP, mm Hg  55±6  65±21  60±8  0.225 
ETco2, mm Hg  39±9  42±4  39±7  0.363 
CI, L/min/m
2  4.4±0.5  4.5±1.9  4.6±1.0  0.982 
7 hours ROSC         
HR, beats/minute  131±17  140±22  127±20  0.821 
MAP, mm Hg  58±4  59±12  61±8  0.820 
ETco2, mm Hg  37±7  35±4  35±2  0.731 
CI, L/min/m
2  6.2±0.4  5.5±1.1  7.1±1.2  0.071 
24 hours ROSC         
HR, beats/minute  154±25  143±19  124±24  0.297 
MAP, mm Hg  46±6  57±12  54±4  0.249 
ETco2, mm Hg  37±4  41±1  37±2  0.180 
CI, L/min/m
2  5.6±0.2  7.1±1.6  8.7±1.8  0.139 
Hemodynamic data were determined at baseline, following return of spontaneous circulation 
(ROSC), and 7 and 24 hours after ROSC. HR indicates heart rate; MAP, mean arterial blood 
pressure; ETco2, end-tidal carbon dioxide, CI, cardiac index; NT, normothermia; HT, hypo-
thermia; HT+SEV, hypothermia combined with sevoflurane. Data are mean ± SD.   
Additional files 
Additional file 1 
Title: Extended Method section - Quantitative real-time RT-PCR.   
Description: Detailed description of quantitative  real-time RT-PCR, primer sequences and 
TaqMan probes.  
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